Serious infections† during randomized retreatment period. Data are number of patients (%).
| Serious Infections | Retreatment with Placebo (n = 155) | Retreatment with Rituximab (n = 320) |
|---|---|---|
| Total serious infections | 3 (2) | 7 (2) |
| Pneumonia* | 1 | 2 |
| Abdominal wall abscess | 1 | 0 |
| Gastroenteritis | 0 | 1 |
| Perirectal abscess | 0 | 1 |
| Urosepsis | 0 | 1 |
| Pyelonephritis | 1 | 0 |
| Bursitis | 0 | 1 |
| Acute respiratory distress syndrome* | 1 | 1 |